研究单位：[1]Shanghai Zhongshan Hospital[2]Zhejiang Zylox Medical Device Co., Ltd.[3]Xuanwu hospital,Beijing,China[4]Affiliated Hospital of Chengde Medical College,Chengde,China[5]The Third People's Hospital of Chengdu,Chengdu,China[6]The First Affiliated Hospital of Dalian Medical University,Dalian,China[7]The Second Affiliated Hospital of Dalian Medical University,Dalian,China[8]Guangzhou Huaqiao hospital,Guangzhou,China[9]Hospital of Traditional Chinese Medicine affiliated to Guangzhou Medical University,Guangzhou,China[10]The Third Affiliated Hospital of Guangzhou Medical University,Guangzhou,China[11]The First Affiliated Hospital of Harbin Medical University,Ha'erbin,China[12]Hangzhou First People's Hospital,Hangzhou,China[13]First Hospital of Lanzhou University,Lanzhou,China[14]Ningbo huamei hospital,Ningbo,China[15]Qingdao Municipal Hospital,Qingdao,China[16]Ruian People's Hospital,Rui'an,China[17]Shanghai Ninth People'S Hospital,Shanghai,China[18]Zhongshan Hospital,Shanghai,China[19]Northern Theatre General Hospital,Shenyang,China[20]Tianjin Medical University General Hospital,Tianjin,China[21]Tianjin People's Hospital,Tianjin,China[22]Weifang People's Hospital,Weifang,China[23]The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China[24]The Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,China[25]The First Affiliated Hospital of Xi 'an Jiaotong University School of Medicine,Xi'an,China[26]People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang,China
研究目的：
The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Drug-coated Balloon catheters in the treatment of the Superficial Femoral Artery (SFA) and Popliteal Arteries (PA).
